Enser (ENSER)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 30.57% shows efficient use of capital.
• Latest quarter net margin around 11% (₹4 crore net profit on ₹36 crore sales).
• Promoter holding of 66.43% aligns interests with minority shareholders.
• P/E of 14.13 is not stretched for a ₹105 crore market cap.

Concerns

• Sales declined 8.61% and profit declined 17.11%.
• Piotroski F-score of 3/9 signals weak financial health.
• No dividend yield, and book value/debt-equity data are unavailable.
• No visible moat in a competitive IT-enabled services industry.

AI Analysis

Enser is a small IT-enabled services company, and when I look at these figures I am reminded that size and simplicity are not the same as safety. The latest quarter shows sales of ₹36 crore and net profit of ₹4 crore, so the net margin is roughly 11 percent — respectable for the quarter. But the longer picture is less encouraging. Sales have declined 8.61 percent and profit is down 17.11 percent, so the company is contracting even as the overall economy grows. A Graham investor must ask: what is the moat? I do not see one in these numbers. IT-enabled services is a competitive field, and with no dividend, the shareholder receives no income while waiting. The positive point is ROCE of 30.57 percent, which suggests the company is earning attractive returns on capital employed. That is a good sign if the business can stop shrinking. The Piotroski F-score of 3 out of 9, however, is a clear warning. It suggests weak financial health and possible deterioration in operations. At ₹16, the market capitalisation is ₹105 crore and the P/E is 14.13. That is not expensive, but a reasonable price cannot compensate for falling sales and profits. Without book value, debt-equity details, or a FairStock score, I am working with incomplete information. Promoter holding of 66.43 percent is a positive, aligning promoters with public shareholders. Still, I would classify this as a possible turnaround situation, not a proven compounder. I need evidence of stabilisation: sales growth, stable margins, and an improved F-score. Until then, I will watch from the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer